IGM Biosciences, Inc. (IGMS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 369.74M |
| Enterprise Value | 388.43M |
| P/E Ratio | -0.39 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 28.93 |
| Price/Book Ratio | 1.6 |
| Enterprise/Revenue | 35.9 |
| Enterprise/EBITDA | -0.48 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -73.09 |
| Operating Margin | -77.86 |
| Return On Assets | -0.74 |
| Return On Equity | -1.56 |
| Revenue | 2.68M |
| Revenue/Share | 0.04 |
| Gross Profit | -6.43M |
| EBITDA | -199.47M |
| Net Income | -195.8M |
| Diluted EPS | -3.24 |
| Total Cash | 104.31M |
| Total Cash/Share | 3.04 |
| Total Debt | 0 |
| Total Debt/Equity | 0.94 |
| Current Ratio | 5.14 |
| Book Value Per Share | 0.8 |
| 52-Week Change | -89.67 |
| 52-Week High | 22.5 |
| 52-Week Low | 0.92 |
| Moving Average 50 Days | 1.27 |
| Moving Average 200 Days | 3.58 |
| Average Volume | 634,437 |
| Shares Outstanding | 61.02M |
| % Held by Institutions | 25.97 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |